Yes, gus66. And on October 22, Chairman Brian Leedman said this: “The newly in-licensed cannabis strains for treating neurological disorders represent tremendous commercial opportunities that match perfectly with the use of our Mente platform for monitoring patients in our forthcoming clinical studies”.
Yes, gus66. And on October 22, Chairman Brian Leedman said this:...
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $65.11M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 281 | 6.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.6¢ | 9859 | 1 |
View Market Depth
| Last trade - 09.18am 07/08/2024 (20 minute delay) ? |
| NTI (ASX) Chart |
Day chart unavailable